CN114190548A - Microecological extract with arteriosclerosis intervention function and preparation method thereof - Google Patents
Microecological extract with arteriosclerosis intervention function and preparation method thereof Download PDFInfo
- Publication number
- CN114190548A CN114190548A CN202111402752.7A CN202111402752A CN114190548A CN 114190548 A CN114190548 A CN 114190548A CN 202111402752 A CN202111402752 A CN 202111402752A CN 114190548 A CN114190548 A CN 114190548A
- Authority
- CN
- China
- Prior art keywords
- parts
- microecological
- extract
- preparing
- extract according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 72
- 206010003210 Arteriosclerosis Diseases 0.000 title claims abstract description 21
- 208000011775 arteriosclerosis disease Diseases 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 241000233866 Fungi Species 0.000 claims abstract description 12
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 12
- 239000004376 Sucralose Substances 0.000 claims abstract description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 10
- 235000019408 sucralose Nutrition 0.000 claims abstract description 10
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 9
- 240000002234 Allium sativum Species 0.000 claims abstract description 9
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 9
- 244000099147 Ananas comosus Species 0.000 claims abstract description 9
- 235000007119 Ananas comosus Nutrition 0.000 claims abstract description 9
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 9
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 9
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 9
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 9
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 9
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims abstract description 9
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 9
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 9
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 9
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 9
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 9
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 9
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims abstract description 9
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 9
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 9
- 240000002624 Mespilus germanica Species 0.000 claims abstract description 9
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 9
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 9
- 244000294611 Punica granatum Species 0.000 claims abstract description 9
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 9
- 244000253911 Saccharomyces fragilis Species 0.000 claims abstract description 9
- 235000018368 Saccharomyces fragilis Nutrition 0.000 claims abstract description 9
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 9
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 9
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 9
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 9
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 9
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 9
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 9
- 235000021014 blueberries Nutrition 0.000 claims abstract description 9
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 9
- 235000004611 garlic Nutrition 0.000 claims abstract description 9
- 229940031154 kluyveromyces marxianus Drugs 0.000 claims abstract description 9
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 9
- 239000001751 lycopene Substances 0.000 claims abstract description 9
- 229960004999 lycopene Drugs 0.000 claims abstract description 9
- 235000012661 lycopene Nutrition 0.000 claims abstract description 9
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 9
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 3
- 238000000605 extraction Methods 0.000 claims description 23
- 244000005700 microbiome Species 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 22
- 230000001954 sterilising effect Effects 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 230000000813 microbial effect Effects 0.000 claims description 21
- 238000003860 storage Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 230000000593 degrading effect Effects 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000575 pesticide Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 4
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 241000894007 species Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 235000021307 Triticum Nutrition 0.000 abstract 1
- 244000098338 Triticum aestivum Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 description 22
- 239000000126 substance Substances 0.000 description 18
- 239000003814 drug Substances 0.000 description 13
- 239000006041 probiotic Substances 0.000 description 12
- 235000018291 probiotics Nutrition 0.000 description 12
- 241000218628 Ginkgo Species 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 230000000529 probiotic effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229940059442 hemicellulase Drugs 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000003987 organophosphate pesticide Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229930010796 primary metabolite Natural products 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000024053 secondary metabolic process Effects 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589159 Agrobacterium sp. Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000877877 Bacillus sp. TAP-1 Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001148106 Brucella melitensis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 241000506874 Delftia sp. Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000405694 Ochrobactrum sp. DDV-1 Species 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 241000228145 Penicillium brevicompactum Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000204735 Pseudomonas nitroreducens Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000736131 Sphingomonas Species 0.000 description 1
- 241000192584 Synechocystis Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000894120 Trichoderma atroviride Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940038698 brucella melitensis Drugs 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- -1 inoculating Substances 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 229940098377 penicillium brevicompactum Drugs 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 229950001664 phoxim Drugs 0.000 description 1
- 229940026314 red yeast rice Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a microecological extract with an arteriosclerosis intervention function, which is prepared from the following components in parts by weight: 2-4 parts of garlic, 6-10 parts of black fungus, 5-7 parts of cinnamon, 6-10 parts of Chinese yam, 18-24 parts of grape, 8-12 parts of blueberry, 4-6 parts of hawthorn, 4-6 parts of pomegranate, 4-6 parts of pineapple, 3-5 parts of purple cabbage, 0.8-1.2 parts of peach kernel, 2.5-3.5 parts of ginkgo, 0.08-0.12 part of medlar powder, 0.25-0.35 part of spirulina platensis, 12-15 parts of fructo-oligosaccharide, 1.2-1.8 parts of oat wheat beta-glucan, 0.005-0.015 part of sucralose, 0.8-1.2 parts of kluyveromyces marxianus and 0.0008-0.0012 part of lycopene. The invention also provides a preparation method of the microecological extract. The microecological extract has the effects of arteriosclerosis intervention and the like.
Description
Technical Field
The invention relates to the field of health-care food, in particular to a microecological extract with an arteriosclerosis intervention function, and also relates to a preparation method of the microecological extract.
Background
With the improvement of living standard of people, various substances such as fat, sugar and the like are more and more ingested, but due to the reasons of high working pressure, little exercise, irregular work and rest time and the like at present, great harm is brought to the cardiovascular health of people, wherein the artery sclerosis becomes a common cardiovascular disease which has great harm to human bodies, and serious people can cause hypertension and even corresponding tissue and organ ischemia necrosis. Therefore, people can treat the diseases through chemical medicines, biological medicines, Chinese herbal medicines and other medicines, but the diseases can be treated after the diseases occur, and firstly, the treatment effect is difficult to ensure; secondly, medicines such as chemical medicines can also cause certain influences on the health of human bodies, such as sequelae, adverse reactions and the like, and although the traditional Chinese herbal medicines have small side effects, the traditional Chinese herbal medicines have more impurities, are inconvenient to take and have low extraction efficiency, so that the curative effect and the application are influenced.
For this reason, microbial extraction of Chinese herbal medicines, edible animal and plant foods, has been started to improve the active ingredients and effects:
for example, the Chinese patent publication No. CN102319278B discloses a red yeast rice compound preparation capable of regulating blood pressure and fat and improving arteriosclerosis, coronary heart disease and cerebral embolism; fermenting ginseng and ginkgo leaf liquid to obtain ginseng and ginkgo fermentation liquor, liquid culturing seeds of monascus 9901 or 9906 strain, adding water into ginseng and ginkgo leaf fermentation liquor and grain to prepare solid culture medium, inoculating, solid fermenting to obtain monascus mould, sterilizing malt juice or potato juice, sugar and agar to prepare flat plate, inoculating, culturing to obtain pure monascus mould, preparing strain expanding culture solution, inoculating, strain protecting and culturing, shaking table culturing, sterilizing, inoculating and culturing ginseng and ginkgo leaf extract and solid fermentation nutrient solution, fermenting to obtain solid culture, sterilizing, drying, crushing, mixing to obtain fine powder of monascus, and preparing the preparation according to corresponding preparation process.
However, people find that the existing microecological extraction has some defects through research:
1) the extraction effect and efficiency are not ideal, and the existing microorganism extraction is limited by the differences of fermentation ways and metabolites of different strains, so that the selection and proportion of microorganism strains can greatly influence the extraction efficiency;
2) the absorption efficiency of the extracted product for human body is not high, and the absorption degree of the produced extract for the gastrointestinal environment of human body still has certain deficiency due to the influence of the whole fermentation environment of the existing microbial extract;
3) harmful substances exist, and the existing Chinese herbal medicines and foods inevitably contain some harmful chemical substances such as pesticide ingredients and the like, which bring certain damage to human bodies.
Therefore, there is a need for a microecological extract which has a higher extraction efficiency, a low toxic component content, a high human absorption, and is capable of arteriosclerosis intervention.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide a microecological extract with an arteriosclerosis intervention function, and also provides a preparation method of the microecological extract.
In order to achieve the purpose, the invention adopts the following technical scheme:
a microecological extract with an arteriosclerosis intervention function is prepared from the following components in parts by weight: 2-4 parts of garlic, 6-10 parts of black fungus, 5-7 parts of cinnamon, 6-10 parts of Chinese yam, 18-24 parts of grape, 8-12 parts of blueberry, 4-6 parts of hawthorn, 4-6 parts of pomegranate, 4-6 parts of pineapple, 3-5 parts of purple cabbage, 0.8-1.2 parts of peach kernel, 2.5-3.5 parts of ginkgo, 0.08-0.12 part of medlar powder, 0.25-0.35 part of spirulina platensis, 12-15 parts of fructo-oligosaccharide, 1.2-1.8 parts of oat beta-glucan, 0.005-0.015 part of sucralose, 0.8-1.2 parts of kluyveromyces marxianus and 0.0008-0.0012 part of lycopene.
In the invention, a further preferable scheme is that the microecological extract is prepared from the following components in parts by weight: 3 parts of garlic, 8 parts of black fungus, 6 parts of cinnamon, 8 parts of Chinese yam, 21.5 parts of grape, 10 parts of blueberry, 5 parts of hawthorn, 5 parts of pomegranate, 5 parts of pineapple, 4 parts of purple cabbage, 1 part of peach kernel, 3 parts of ginkgo, 0.1 part of medlar powder, 0.299 parts of spirulina platensis, 13.59 parts of fructo-oligosaccharide, 1.5 parts of oat beta-glucan, 0.01 part of sucralose, 1 part of kluyveromyces marxianus and 0.001 part of lycopene.
The invention also provides a preparation method of the microecological extract, which comprises the following steps:
step 1: taking the components according to the formula, mixing, sterilizing, and then breaking the wall by microwave to obtain a crushed raw material mixture;
step 2: carrying out microbial ecological extraction treatment on the raw material mixture obtained in the step 1 by using microbes, then filtering the mixture obtained after the microbial ecological extraction, removing filter residues, and collecting a microbial ecological extracting solution;
and step 3: and (3) sterilizing the microecological extracting solution obtained in the step (2), and then curing to obtain the microecological extract.
In the present invention, it is further preferable that the method further comprises, after the step 3, a step 4: adding food acceptable auxiliary materials into the microecological extract obtained in the step 3.
In the present invention, it is further preferable that step 4 is followed by step 5: heating the microecological extract treated in the step 4 until the auxiliary materials are dissolved, and then sterilizing; the adjuvant is soluble in water.
In the present invention, it is further preferable that the sterilization is performed by ozone.
In the invention, a further preferable scheme is that the extraction temperature in the step 2 is 35-39 ℃, and the extraction time is 2-4 years.
In the present invention, it is further preferable that the aging treatment in the step 3 specifically comprises: and (3) placing the microecological extracting solution into a sterilized curing barrel for sealed curing storage, wherein the temperature for sealed curing storage is room temperature.
In the present invention, it is further preferred that the microorganism in step 2 comprises the following strains in percentage by weight of the total amount of each component (the percentage by weight herein refers to the ratio of the amount of the strains to the total weight of each component of the microecological extract x 100%): 0.0133% of lactobacillus acidophilus, 0.0133% of lactobacillus casei, 0.0133% of lactobacillus rhamnosus, 0.01% of lactobacillus reuteri, 0.01% of streptococcus thermophilus and 0.02% of bifidobacterium animalis.
In the present invention, it is further preferable that the microorganism in step 2 further includes a microorganism for degrading an organophosphorus pesticide.
Compared with the prior art, the invention has the beneficial effects that the microecological extract has the following effects by screening and proportioning optimization of fermentation microbial strains:
1) the probiotic composition has high content of active ingredients, and can secrete protease, cellulase, hemicellulase, pectinase, amylase and other extracellular enzymes in the process of growing, reproducing and metabolizing by using each component as a nutrient substance, so that cells of the traditional Chinese medicine are cracked, the active ingredients of each component can be released from the cells, and the active ingredients in each component can be extracted and utilized to the maximum extent; has arteriosclerosis intervention function;
2) the beneficial component content is high, and the probiotic composition can generate substances such as polysaccharide beneficial to a human body in the secondary metabolism process, and finally enter the extracting solution to improve the content of the beneficial substances in the extracting solution;
3) the probiotic composition disclosed by the invention has high human body absorptivity, macromolecular substances which cannot be absorbed by a human body are degraded into active micromolecules which can be absorbed by the human body, and the micromolecular substances can be combined with cell proteins of an organism through a blood brain barrier, so that the absorption and utilization of the organism to effective components are improved;
4) the probiotics extracting method has the advantages that the variety of active ingredients is various, in the process of extracting the probiotics through combination, part of the ingredients in each component have inhibition/promotion effects on the growth and metabolism of microorganisms and the generation of the active ingredients, and the microorganisms can change own metabolic pathways in the special environment of each component, so that richer primary or secondary metabolites are generated, and more active ingredients are formed;
5) the probiotic composition disclosed by the invention can degrade toxic components in the traditional Chinese medicine components, such as alkaloids, glycosides, lactones, protein heavy metals and the like, or structurally modify toxic active ingredients of the traditional Chinese medicine, so that the toxic and side effects are reduced;
6) active ingredients are prevented from being damaged, and the damage to the active ingredients in the traditional Chinese medicine decocting, boiling, steaming, refining and other processes is avoided by adopting a microecological extraction process;
in addition, the preparation method is easy to operate and convenient for industrial production.
Detailed Description
The present invention is further described below with reference to specific embodiments, and it should be noted that, without conflict, any combination between the embodiments or technical features described below may form a new embodiment. Except as specifically noted, the materials and equipment used in this example are commercially available. The specific embodiments are merely illustrative and are not to be construed as limiting the scope of the invention.
A microecological extract with an arteriosclerosis intervention function is prepared from the following components in parts by weight: 2-4 parts of garlic, 6-10 parts of black fungus, 5-7 parts of cinnamon, 6-10 parts of Chinese yam, 18-24 parts of grape, 8-12 parts of blueberry, 4-6 parts of hawthorn, 4-6 parts of pomegranate, 4-6 parts of pineapple, 3-5 parts of purple cabbage, 0.8-1.2 parts of peach kernel, 2.5-3.5 parts of ginkgo, 0.08-0.12 part of medlar powder, 0.25-0.35 part of spirulina platensis, 12-15 parts of fructo-oligosaccharide, 1.2-1.8 parts of oat beta-glucan, 0.005-0.015 part of sucralose, 0.8-1.2 parts of kluyveromyces marxianus and 0.0008-0.0012 part of lycopene.
Through the screening and the proportioning optimization of the fermentation microbial strains, the microecological extract has the following effects:
1) the probiotic composition has high content of active ingredients, and can secrete protease, cellulase, hemicellulase, pectinase, amylase and other extracellular enzymes in the process of growing, reproducing and metabolizing by using each component as a nutrient substance, so that cells of the traditional Chinese medicine are cracked, the active ingredients of each component can be released from the cells, and the active ingredients in each component can be extracted and utilized to the maximum extent; has arteriosclerosis intervention function;
2) the beneficial component content is high, and the probiotic composition can generate substances such as polysaccharide beneficial to a human body in the secondary metabolism process, and finally enter the extracting solution to improve the content of the beneficial substances in the extracting solution;
3) the probiotic composition disclosed by the invention has high human body absorptivity, macromolecular substances which cannot be absorbed by a human body are degraded into active micromolecules which can be absorbed by the human body, and the micromolecular substances can be combined with cell proteins of an organism through a blood brain barrier, so that the absorption and utilization of the organism to effective components are improved;
4) the probiotics extracting method has the advantages that the variety of active ingredients is various, in the process of extracting the probiotics through combination, part of the ingredients in each component have inhibition/promotion effects on the growth and metabolism of microorganisms and the generation of the active ingredients, and the microorganisms can change own metabolic pathways in the special environment of each component, so that richer primary or secondary metabolites are generated, and more active ingredients are formed;
5) the probiotic composition disclosed by the invention can degrade toxic components in the traditional Chinese medicine components, such as alkaloids, glycosides, lactones, protein heavy metals and the like, or structurally modify toxic active ingredients of the traditional Chinese medicine, so that the toxic and side effects are reduced;
6) avoids the damage of active ingredients, adopts a microecological extraction process, and avoids the damage of the active ingredients in the traditional Chinese medicine processes of decocting, boiling, steaming, refining and the like.
The preparation method of the microecological extract comprises the following steps:
step 1: taking the components according to the formula, mixing, sterilizing, and then breaking the wall by microwave to obtain a crushed raw material mixture;
step 2: carrying out microbial ecological extraction treatment on the raw material mixture obtained in the step 1 by using microbes, then filtering the mixture obtained after the microbial ecological extraction, removing filter residues, and collecting a microbial ecological extracting solution;
and step 3: and (3) sterilizing the microecological extracting solution obtained in the step (2), and then curing to obtain the microecological extract.
In order to be more convenient for consumers to eat, auxiliary materials acceptable for food can be added into the microecological extract obtained in the step 3 to prepare different product dosage forms so as to enrich the mouthfeel of the product and facilitate storage and transportation, and specifically, a sweetening agent and the like can be added according to the needs or the preference of consumers, or the microecological extract is further prepared into oral liquid, tablets and the like; for example, step 4 is followed by step 5: heating the microecological extract treated in the step 4 until the auxiliary materials are dissolved, and then sterilizing; the adjuvants are soluble in water, and can be sweetener (such as granulated sugar, sucralose, mogroside), etc.
In order to improve the quality of the microecological extract, the fermentation temperature in the step 2 is 35-39 ℃, and the fermentation time is 2-4 years.
The sterilization treatment is not particularly limited, and for the sake of facilitating industrial operation, ozone sterilization treatment may be employed for 4 to 8 min.
For filtering the microorganism extract, a 100-mesh sieve can be selected for filtering; for the sterilization treatment of the microorganism extract in step 3, pasteurization can be carried out, such as sterilization at 85 + -5 deg.C for 30-35 min; after the microbial extracting solution is treated in the steps 4 and 5, the treatment such as sterilization, filling, packaging and the like can be continuously carried out for facilitating the storage and transportation of the product; in order to inspect and monitor the quality of the product, the physical and chemical indexes of the product, such as total acid, crude polysaccharide, free amino acid, short-chain fatty acid, microorganism and the like, can be detected.
In order to enhance the flavor of the microbial extract of the present invention, a curing treatment may be performed, and the curing treatment in step 3 is specifically: placing the micro-ecological extracting solution into a sterilized curing barrel for sealed curing storage, wherein the temperature for sealed curing storage is room temperature; by aging, fructo-oligosaccharide in the microorganism extractive solution can be aged to generate aromatic hydrocarbon, which can improve flavor and aromatic hydrocarbon effect.
In order to improve the active ingredient content and the human body availability of the microbial extract and reduce the content of harmful substances, the microbes in the step 2 comprise the following strains in percentage by weight according to the total amount of the components: 0.0133% of lactobacillus acidophilus, 0.0133% of lactobacillus casei, 0.0133% of lactobacillus rhamnosus, 0.01% of lactobacillus reuteri, 0.01% of streptococcus thermophilus and 0.02% of bifidobacterium animalis.
In order to further reduce the content of harmful substances in the microecological extract of the present invention, the microorganisms in step 2 further include microorganisms for degrading organophosphorus pesticides; as the microorganism for degrading the organophosphorus pesticide, bacteria, fungi and algae can be selected, and correspondingly such as:
chlorpyrifos is degraded, and the following bacteria can be selected: bacillus subtilis inaquosum strain KCT C13429, Bacillus cereus ATCC 14579Bacillus safensis F0-36b, Sphingomonas sp, Pseudomonas nitroreducens PS-2, Pseudomonas fluorescens, Brucella melitensis, Bacillus subtilis, Bacillus cereus, Klebsiella sp, Serratia sp, Pseudomonas aeruginosa, Pseudomonas sp, Agrobacterium sp, Bacillus p Ulmus C2A1, the following fungi can be selected: aspergillus terreus, Trichoderma harzianum, Penicillium brevicompactum, Trichoderma sp, optionally algae Synechocystis PUPCCC 64;
the phoxim can be degraded by the following bacteria: plouomonas sp.X-1, Delftia sp.XSP-1, Bacillus subtilis Bs-15, Stenotrophoromonas sp.G1, Ochrobactrum sp.DDV-1; the following fungi may be selected: paecilomyces larlicinus NH-PL-03, Trichoderma atroviride;
degrading trichlorfon by using Rhodobacter sphaeroides, and degrading triazophos by using Stenotrophormonas sp.G1 and Bacillus sp.TAP-1;
specifically, in the microecological extraction process of the present invention, the above-listed microorganisms may be selected based on the need, one or a combination of two or more of them may be selected, or other microorganisms not listed may be selected based on the need to be combined with the above-listed microorganisms.
Example 1
A microecological extract with an arteriosclerosis intervention function is prepared from the following components in parts by weight: 3 parts of garlic, 8 parts of black fungus, 6 parts of cinnamon, 8 parts of Chinese yam, 21.5 parts of grape, 10 parts of blueberry, 5 parts of hawthorn, 5 parts of pomegranate, 5 parts of pineapple, 4 parts of purple cabbage, 1 part of peach kernel, 3 parts of ginkgo, 0.1 part of medlar powder, 0.299 parts of spirulina platensis, 13.59 parts of fructo-oligosaccharide, 1.5 parts of oat beta-glucan, 0.01 part of sucralose, 1 part of kluyveromyces marxianus and 0.001 part of lycopene;
the preparation method of the ferment comprises the following steps:
step 1: taking the components according to the formula, mixing, sterilizing, and then carrying out superfine grinding to obtain a ground raw material mixture;
step 2: carrying out microbial ecological extraction treatment on the raw material mixture obtained in the step 1 for 150 days by using microbes, then filtering (sieving by a 100-mesh sieve) the mixture obtained after the microbial ecological extraction, removing filter residues, and collecting a microbial ecological extracting solution; comprises the following strains in percentage by weight of the total amount of the components: lactobacillus acidophilus 0.0133%, lactobacillus casei 0.0133%, lactobacillus rhamnosus 0.0133%, lactobacillus reuteri 0.01%, streptococcus thermophilus 0.01%, and animal bifidobacterium 0.02%;
and step 3: sterilizing the microecological extracting solution obtained in the step 2, and then curing to obtain a microecological extract; the curing treatment in the step 3 specifically comprises the following steps: placing the micro-ecological extracting solution into a sterilized curing barrel for sealed curing storage, wherein the temperature for sealed curing storage is room temperature; obtaining the microecological extract.
Example 2
A microecological extract with an arteriosclerosis intervention function is prepared from the following components in parts by weight: 4 parts of garlic, 10 parts of black fungus, 7 parts of cinnamon, 6 parts of Chinese yam, 24 parts of grape, 8 parts of blueberry, 6 parts of hawthorn, 4 parts of pomegranate, 6 parts of pineapple, 5 parts of purple cabbage, 0.8 part of peach kernel, 2.5 parts of ginkgo, 0.08 part of medlar powder, 0.35 part of spirulina platensis, 12 parts of fructo-oligosaccharide, 1.2 parts of oat beta-glucan, 0.005 part of sucralose, 0.8 part of Kluyveromyces marxianus and 0.0008 part of lycopene; the microbial strains and the proportion in the step 2 are the same as those in the example 1; the preparation method is the same as that of example 1.
Example 3
A microecological extract with an arteriosclerosis intervention function is prepared from the following components in parts by weight: 2 parts of garlic, 6 parts of black fungus, 5 parts of cinnamon, 10 parts of Chinese yam, 18 parts of grape, 12 parts of blueberry, 4 parts of hawthorn, 6 parts of pomegranate, 4-6 parts of pineapple, 3 parts of purple cabbage, 0.8 part of peach kernel, 3.5 parts of ginkgo, 0.12 part of medlar powder, 0.25 part of spirulina platensis, 15 parts of fructo-oligosaccharide, 1.8 parts of oat beta-glucan, 0.015 part of sucralose, 1.2 parts of Kluyveromyces marxianus and 0.0012 part of lycopene; the microbial strains and the proportion in the step 2 are the same as those in the example 1; the preparation method is the same as that of example 1.
Experimental example 1
Taking the microecological extract with the arteriosclerosis intervention function in example 1, and then detecting the contents of polyphenol, flavone, saponin, amino acid and harmful substances in the microecological extract, wherein the specific detection results are shown in the following tables 1-3:
TABLE 1 active ingredient content test Table in microecological extracts
As can be seen from the data in table 1 above: the microecological extract with the arteriosclerosis intervention function has high contents of polyphenol, flavone, polysaccharide, saponin and the like, has high superoxide dismutase (SOD) activity, and can well intervene arteriosclerosis.
TABLE 2 test chart of amino acid content in microecological extract
As can be seen from the data in table 2 above: the microecological extract with the arteriosclerosis intervention function has complete types and high content of essential amino acids for human bodies.
TABLE 3 test chart for contents of some harmful components in microecological extract
As can be seen from the data in table 3 above: the microecological extract with the arteriosclerosis intervention function has no other harmful substances except lactic acid, and has high safety.
TABLE 4 test chart for part of heavy metal content and part of pesticide content in microecological extract
From the data in table 4 above, it can be seen that the microecological extract of the present invention in example 1 was not detected for each heavy metal and pesticide, and was highly safe.
TABLE 5 test Table for colony content in microecological extract
From the detection data in table 5 above, it can be seen that each harmful bacterium and saccharin sodium in the microecological extract of the present invention all meet the national standards, and the microecological extract of the present invention has high safety.
Comparative example 1
Taking the components according to the microecological components and the proportion thereof in the embodiment 1, mixing, sterilizing, and then carrying out superfine grinding to obtain a ground raw material mixture; and adding water, decocting for 3 times, decocting for 30min each time, collecting the filtrate obtained by 3 times of decoction through filtration, and combining the filtrates to obtain the filtrate of comparative example 1 (namely the extract of comparative example 1).
Respectively taking 2 parts of the same weight of the microecological formulation according to the example 1, then respectively adopting the methods of the example 1 and the comparative example 1 to obtain the microecological extract of the example 1 and the extract of the comparative example 1, concentrating the 2 parts of the extract to the same weight (concentrating the extract of the comparative example 1 to the same weight based on the microecological extract of the example 1), then respectively testing the content of each nutrient component and the total amount of hydrolyzed amino acid in the extract, wherein the test result data are shown in the following table:
table 6: data table for active nutrient ingredient content test of example 1 and comparative example 1
As can be seen from the data in Table 6, compared with the conventional decoction process of comparative example 1, the microecological extraction of the present invention enables better release of active nutritional ingredients, so that the microecological extract of the present invention has higher nutritional active ingredients and better intervention effect on the anti-atherosclerosis ability of the human body.
Finally, it should be noted that: the above embodiments are only preferred embodiments of the present invention, and the protection scope of the present invention should not be limited thereby, and any insubstantial changes and substitutions made by those skilled in the art based on the present invention are within the protection scope of the present invention.
Claims (10)
1. A microecological extract with an arteriosclerosis intervention function is characterized by being prepared from the following components in parts by weight: 2-4 parts of garlic, 6-10 parts of black fungus, 5-7 parts of cinnamon, 6-10 parts of Chinese yam, 18-24 parts of grape, 8-12 parts of blueberry, 4-6 parts of hawthorn, 4-6 parts of pomegranate, 4-6 parts of pineapple, 3-5 parts of purple cabbage, 0.8-1.2 parts of peach kernel, 2.5-3.5 parts of ginkgo, 0.08-0.12 part of medlar powder, 0.25-0.35 part of spirulina platensis, 12-15 parts of fructo-oligosaccharide, 1.2-1.8 parts of oat beta-glucan, 0.005-0.015 part of sucralose, 0.8-1.2 parts of kluyveromyces marxianus and 0.0008-0.0012 part of lycopene.
2. The microecological extract according to claim 1, which is prepared from the following components in parts by weight: 3 parts of garlic, 8 parts of black fungus, 6 parts of cinnamon, 8 parts of Chinese yam, 21.5 parts of grape, 10 parts of blueberry, 5 parts of hawthorn, 5 parts of pomegranate, 5 parts of pineapple, 4 parts of purple cabbage, 1 part of peach kernel, 3 parts of ginkgo, 0.1 part of medlar powder, 0.299 parts of spirulina platensis, 13.59 parts of fructo-oligosaccharide, 1.5 parts of oat beta-glucan, 0.01 part of sucralose, 1 part of kluyveromyces marxianus and 0.001 part of lycopene.
3. A method for preparing the microecological extract according to claim 1, characterized in that it comprises the steps of:
step 1: taking the components according to the formula, mixing, sterilizing, and then breaking the wall by microwave to obtain a crushed raw material mixture;
step 2: carrying out microbial ecological extraction treatment on the raw material mixture obtained in the step 1 by using microbes, then filtering the mixture obtained after the microbial ecological extraction, removing filter residues, and collecting a microbial ecological extracting solution;
and step 3: and (3) sterilizing the microecological extracting solution obtained in the step (2), and then curing to obtain the microecological extract.
4. The method for preparing a microecological extract according to claim 3, further comprising the step 4 after the step 3: adding food acceptable auxiliary materials into the microecological extract obtained in the step 3.
5. The method for preparing a microecological extract according to claim 4, further comprising the step 5 after the step 4: heating the microecological extract treated in the step 4 until the auxiliary materials are dissolved, and then sterilizing; the adjuvant is soluble in water.
6. The method for preparing a microecological extract according to claim 3, wherein the sterilization is by ozone.
7. The method for preparing a microecological extract according to claim 3, wherein: the extraction temperature in the step 2 is 35-39 ℃, and the extraction time is 2-4 years.
8. The method for preparing a microecological extract according to claim 3, wherein the aging treatment in the step 3 is specifically: and (3) placing the microecological extracting solution into a sterilized curing barrel for sealed curing storage, wherein the temperature for sealed curing storage is room temperature.
9. The method for preparing a microecological extract according to claim 3, wherein the microorganisms of step 2 comprise the following species in percentage by weight based on the total amount of each component: 0.0133% of lactobacillus acidophilus, 0.0133% of lactobacillus casei, 0.0133% of lactobacillus rhamnosus, 0.01% of lactobacillus reuteri, 0.01% of streptococcus thermophilus and 0.02% of bifidobacterium animalis.
10. The method for preparing a microecological extract according to claim 3, wherein the microorganisms of step 2 further comprise microorganisms for degrading organophosphorus pesticides.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111402752.7A CN114190548A (en) | 2021-11-24 | 2021-11-24 | Microecological extract with arteriosclerosis intervention function and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111402752.7A CN114190548A (en) | 2021-11-24 | 2021-11-24 | Microecological extract with arteriosclerosis intervention function and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114190548A true CN114190548A (en) | 2022-03-18 |
Family
ID=80648636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111402752.7A Pending CN114190548A (en) | 2021-11-24 | 2021-11-24 | Microecological extract with arteriosclerosis intervention function and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114190548A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117562931A (en) * | 2024-01-15 | 2024-02-20 | 上海昌进生物科技有限公司 | Composition containing Kluyveromyces marxianus thallus, preparation method and application |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106579413A (en) * | 2016-12-23 | 2017-04-26 | 高密大德酵素有限公司 | Hua'e Mountain Fritillaria cirrhosa enzyme and preparation method thereof |
| CN106729092A (en) * | 2016-12-29 | 2017-05-31 | 山东龙力生物科技股份有限公司 | A kind of blood fat reducing preparation containing xylo-oligosaccharide and its preparation method and application |
| CN106974279A (en) * | 2017-04-11 | 2017-07-25 | 姜红成 | Prepare the fermentation composition and preparation method for being applied to cardiovascular and cerebrovascular diseases conditioning and its routine servicing effect plant enzyme |
| CN107334100A (en) * | 2017-06-29 | 2017-11-10 | 张萌 | Bird's nest composite enzyme and preparation method thereof |
| CN108112987A (en) * | 2017-12-12 | 2018-06-05 | 广州农信饲料有限公司 | A kind of functional preparation for adjusting gastrointestinal health and its preparation method and application |
| CN108938789A (en) * | 2018-08-13 | 2018-12-07 | 安吉艾格赛思生物科技有限公司 | A kind of more bacterium combination formulations of the adjusting intestinal microecology containing xylo-oligosaccharide |
-
2021
- 2021-11-24 CN CN202111402752.7A patent/CN114190548A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106579413A (en) * | 2016-12-23 | 2017-04-26 | 高密大德酵素有限公司 | Hua'e Mountain Fritillaria cirrhosa enzyme and preparation method thereof |
| CN106729092A (en) * | 2016-12-29 | 2017-05-31 | 山东龙力生物科技股份有限公司 | A kind of blood fat reducing preparation containing xylo-oligosaccharide and its preparation method and application |
| CN106974279A (en) * | 2017-04-11 | 2017-07-25 | 姜红成 | Prepare the fermentation composition and preparation method for being applied to cardiovascular and cerebrovascular diseases conditioning and its routine servicing effect plant enzyme |
| CN107334100A (en) * | 2017-06-29 | 2017-11-10 | 张萌 | Bird's nest composite enzyme and preparation method thereof |
| CN108112987A (en) * | 2017-12-12 | 2018-06-05 | 广州农信饲料有限公司 | A kind of functional preparation for adjusting gastrointestinal health and its preparation method and application |
| CN108938789A (en) * | 2018-08-13 | 2018-12-07 | 安吉艾格赛思生物科技有限公司 | A kind of more bacterium combination formulations of the adjusting intestinal microecology containing xylo-oligosaccharide |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117562931A (en) * | 2024-01-15 | 2024-02-20 | 上海昌进生物科技有限公司 | Composition containing Kluyveromyces marxianus thallus, preparation method and application |
| CN117562931B (en) * | 2024-01-15 | 2024-04-30 | 上海昌进生物科技有限公司 | Composition containing Kluyveromyces marxianus thallus, preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105054040B (en) | A kind of composition of probiotics fermention ginseng and its preparation method and application | |
| KR101370386B1 (en) | Preparation method of fermented red ginseng using effective micro-organisms | |
| TW200944137A (en) | Method for manufacturing health food containing enzyme, and health food | |
| KR20120125042A (en) | A process for preparing a fermented broth of herbal medicine by combined microorganisms, a fermented broth prepared by the process, and a fermented food prepared by the fermented broth | |
| CN105146660B (en) | Natural fruit and vegetables enzyme beverage and preparation method thereof | |
| JP2004049154A (en) | Fermented carrot containing decomposed product of saponin and method for producing the same | |
| KR102379524B1 (en) | Composition for improving, treating or preventing intestinal function or inflammarory bowel disease comprising fermented rice as an active ingredient | |
| US20100040732A1 (en) | Compositions and Methods for Fermented Nutraceuticals | |
| CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
| CN110916177A (en) | Method for preparing kelp enzyme by enzyme fermentation coupling technology | |
| CN102851259B (en) | Preparation method of antioxidant | |
| KR101276789B1 (en) | Fermented oil and a health functional food comprising the same | |
| CN114190548A (en) | Microecological extract with arteriosclerosis intervention function and preparation method thereof | |
| KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
| CN105559087A (en) | Probiotic product containing sialic acid and preparation method of probiotic product | |
| KR102133721B1 (en) | functional food composition for antioxidant effect comprising fermented permission leaf | |
| JP2002065199A (en) | Method for producing fermented turmeric | |
| KR101368634B1 (en) | Health functional food comprising Ginseng cultivates fermentation and method for manufacturing thereof | |
| CN114947119A (en) | Walnut flower fermented food with auxiliary blood sugar and blood fat reducing effect and preparation method thereof | |
| KR101713176B1 (en) | Fermented medicinal-herb composition having antioxidation activity and and method for preparing thereof | |
| CN108703289A (en) | Using spirulina and sea buckthorn juice as the probiotics drink and preparation method of raw material | |
| CN114403442A (en) | Mustard extract synbiotics and preparation method thereof | |
| KR102055053B1 (en) | Starter containing of lactic acid bacteria with superior effect for alcohol degradation activity and cheese containing alcohol metabolism using the same | |
| JP4647933B2 (en) | Composition having intestinal regulating action | |
| CN114223892A (en) | Microecological extract with function of reducing uric acid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |